Immunogenicity and tolerability of an investigational formulation of interferon-β1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis

✍ Scribed by Gavin Giovannoni; Olga Barbarash; Florence Casset-Semanaz; Amer Jaber; John King; Luanne Metz; Gabriel Pardo; James Simsarian; Per Soelberg Sørensen; Bettina Stubinski

• Book ID: 116371986
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 222 KB
• Volume: 29
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2007.06.002